We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current NRBO market cap is 20.33M. The company's latest EPS is USD -1.4473 and P/E is -1.20.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.89M | -5.67M | -6.88M | -10.08M | -6.26M |
| Net Income | -3.82M | -5.31M | -6.71M | -10.05M | -5.65M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -20.18M | -29.72M | -15.3M | -19.63M | -15.89M |
| Net Income | -21.31M | -29.68M | -15.28M | -13.97M | -12.47M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 26.43M | 22.78M | 17.02M | 28.75M | 22.15M |
| Total Liabilities | 4.88M | 6.1M | 6.94M | 9.81M | 9.19M |
| Total Equity | 21.55M | 16.69M | 10.08M | 18.94M | 12.95M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 14.47M | 10.97M | 16.8M | 33.53M | 22.78M |
| Total Liabilities | 2.18M | 3.77M | 2.2M | 11.78M | 6.1M |
| Total Equity | 12.29M | 7.2M | 14.6M | 21.75M | 16.69M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.41M | -10.8M | -6.44M | -13.69M | -19.28M |
| Investing | -41k | -50k | -5k | -8k | -8k |
| Financing | -80k | -80k | N/A | 19.2M | 18.52M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.04M | -10.76M | -15.13M | -11.71M | -10.8M |
| Investing | -6.06M | 69k | -586k | 8k | -50k |
| Financing | 24.17M | 6.86M | 22.03M | 28.68M | -80k |
| Market Cap | 20.33M |
| Price to Earnings Ratio | -1.20 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.67 |
| Price to Book Ratio | 0.9 |
| Dividend Yield | - |
| Shares Outstanding | 8.62M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -52.03% |
| 52 Week High | 6.7499 |
| 52 Week Low | 2.08 |
| Spread (Intraday) | 0.18 (7.23%) |
| Company Name | NeuroBo Pharmaceuticals Inc |
| Address |
108 west 13th st wilmington, delaware 19801 |
| Website | https://www.neurobopharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
